| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10217943 | Gastrointestinal Endoscopy | 2018 | 8 Pages |
Abstract
In expert hands, the novel MBM device proved to be effective for resection of early neoplastic lesions in BE, with successful ER in 97% of procedures. Severe adverse events were rare and were effectively managed endoscopically or conservatively. (Clinical trial registration number: NCT02482701.)
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Roos E. MD, PhD, Torsten MD, PhD, Kamar MD, Arjun D. MD, PhD, Erik J. MD, PhD, Rehan MD, PhD, Bas L. MD, PhD, Raf MD, PhD, Nicholas J. MD, PhD, Michael B. MD, PhD, Norman MD, PhD, Rachel MD, PhD, Anniek W. MD, Kenneth K. MD, PhD, Cadman L. MD, PhD,